Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review

Misuzu Tsunoda MD , Takeya Adachi MD, PhD , Yuuri Nakajima MD , Yoshihiro Yatomi MD , Tomoko Shimizu MD, PhD , Katsuki Nakasute MD
{"title":"Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review","authors":"Misuzu Tsunoda MD ,&nbsp;Takeya Adachi MD, PhD ,&nbsp;Yuuri Nakajima MD ,&nbsp;Yoshihiro Yatomi MD ,&nbsp;Tomoko Shimizu MD, PhD ,&nbsp;Katsuki Nakasute MD","doi":"10.1016/j.jacig.2024.100323","DOIUrl":null,"url":null,"abstract":"<div><p>Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.</p></div>","PeriodicalId":75041,"journal":{"name":"The journal of allergy and clinical immunology. Global","volume":"3 4","pages":"Article 100323"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277282932400119X/pdfft?md5=e2cefb2bbc0ec8490f41e39229f8fe37&pid=1-s2.0-S277282932400119X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of allergy and clinical immunology. Global","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277282932400119X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用 JAK 抑制剂成功治疗杜必鲁单抗诱发的银屑病皮炎/关节炎和特应性皮炎:病例报告和文献综述
一位特应性皮炎患者因使用杜匹单抗引发的银屑病皮炎和关节炎,在使用达帕替尼后得到了有效控制,这凸显了使用Janus激酶抑制剂治疗生物疗法副作用的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
The journal of allergy and clinical immunology. Global
The journal of allergy and clinical immunology. Global Immunology, Allergology and Rheumatology
CiteScore
0.70
自引率
0.00%
发文量
0
审稿时长
92 days
期刊最新文献
Reply Editorial board A different lens to explore health literacy skills in atopic conditions Anti–IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis Investigating health care pathways for anaphylaxis: Seeing the bigger picture through linked data
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1